COVID drug Paxlovid was hailed as a game-changer. What happened?
Insufficient investment and fears about rebound and side effects are driving down use of a lifesaving antiviral.
Insufficient investment and fears about rebound and side effects are driving down use of a lifesaving antiviral.
Blood Cancer Journal – What have we learned about TP53-mutated acute myeloid leukemia?
Nature – A spatially resolved single-cell transcriptomics map of the mouse brain at different ages reveals signatures of ageing, rejuvenation and disease, including ageing effects…
Nature Cancer – Mellman and colleagues present a multiomic single-cell analysis of the effects of combined anti-TIGIT and anti-PD-1 blockade on T cell populations trafficking…
Nature – Two-year collaboration aims to create tools to help counter the tide of flawed research.
Nature Reviews Rheumatology – In a phase III clinical trial of abatacept for idiopathic inflammatory myopathy, the primary endpoint was not met but the results…
Nature Reviews Rheumatology – The updated 2023 EULAR recommendations for treatment of systemic sclerosis bring notable changes to recommendations for skin, peripheral vascular disease, interstitial…
Nature Communications – Osada et al. used MRI and brain stimulation to outline the macroscopic cerebral circuits for response inhibition: visual cortex→dorsal anterior insula→inferior…
Nature Communications – Androgen response elements (AREs) regulation produce opposite effects in normal and cancer prostate cells. Here, authors engineer a modifier of ARE-containing chromatin…
Nature Reviews Gastroenterology & Hepatology – Pancreatic cancer remains one of the most challenging malignancies, with a very poor prognosis. Current research is focused on…
Nature Reviews Gastroenterology & Hepatology – Pancreatic cancer remains one of the most challenging malignancies, with a very poor prognosis. Current research is focused on…